Perjeta (Pertuzumab) Medicine

Medical Evidence pertuzumab

Generic name : Pertuzumab.

Trade name : Perjeta.

Manufacturer information :

Perjeta is manufactured by Genentech.

Perjeta FDA Approval :

Perjeta first approvedJune 8th, 2012.

Perjeta Dosage form :

420 mg/14 mL single-use vial.

Perjeta Indications and Usage :

Metastatic Breast Cancer

Indicated in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancer in patients who have not received prior anti-HER2 therapy or chemotherapy for metastatic disease.

Perjeta (Pertuzumab) availability in India

  • You could import this medicine against import permit on Patient Name.
  • Please contact ACT Lifesciences Private Limited for further information.